Literature DB >> 27860276

Regulation of kynurenine biosynthesis during influenza virus infection.

Lana Gaelings1, Sandra Söderholm2,3, Andrii Bugai4, Yu Fu1, Jatin Nandania1, Bert Schepens5,6, Martina B Lorey3, Janne Tynell7, Liesbeth Vande Ginste4,5, Ronan Le Goffic8, Matthew S Miller9, Marika Kuisma4, Varpu Marjomäki10, Jef De Brabander11, Sampsa Matikainen3, Tuula A Nyman12, Dennis H Bamford2, Xavier Saelens4,5, Ilkka Julkunen7,13, Henrik Paavilainen13, Veijo Hukkanen13, Vidya Velagapudi1, Denis E Kainov1.   

Abstract

Influenza A viruses (IAVs) remain serious threats to public health because of the shortage of effective means of control. Developing more effective virus control modalities requires better understanding of virus-host interactions. It has previously been shown that IAV induces the production of kynurenine, which suppresses T-cell responses, enhances pain hypersensitivity and disturbs behaviour in infected animals. However, the regulation of kynurenine biosynthesis during IAV infection remains elusive. Here we showed that IAV infection induced expression of interferons (IFNs), which upregulated production of indoleamine-2,3-dioxygenase (IDO1), which catalysed the kynurenine biosynthesis. Furthermore, IAV attenuated the IDO1 expression and the production of kynurenine through its NS1 protein. Interestingly, inhibition of viral replication prior to IFN induction limited IDO1 expression, while inhibition after did not. Finally, we showed that kynurenine biosynthesis was activated in macrophages in response to other stimuli, such as influenza B virus, herpes simplex virus 1 and 2 as well as bacterial lipopolysaccharides. Thus, the tight regulation of the kynurenine biosynthesis by host cell and, perhaps, pathogen might be a basic signature of a wide range of host-pathogen interactions, which should be taken into account during development of novel antiviral and antibacterial drugs.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  host-pathogen interaction; indoleamine-pyrrole 2,3-dioxygenase (IDO1); influenza virus; innate immunity; interferon

Mesh:

Substances:

Year:  2016        PMID: 27860276     DOI: 10.1111/febs.13966

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  19 in total

1.  Type I Interferons Act Directly on Nociceptors to Produce Pain Sensitization: Implications for Viral Infection-Induced Pain.

Authors:  Paulino Barragán-Iglesias; Úrzula Franco-Enzástiga; Vivekanand Jeevakumar; Stephanie Shiers; Andi Wangzhou; Vinicio Granados-Soto; Zachary T Campbell; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2020-04-03       Impact factor: 6.167

2.  Decreased IDO1-dependent tryptophan metabolism in aged lung during influenza.

Authors:  Soo Jung Cho; Kyung Sook Hong; Edward Schenck; Stefi Lee; Rebecca Harris; Jianjun Yang; Augustine M K Choi; Heather Stout-Delgado
Journal:  Eur Respir J       Date:  2021-05-13       Impact factor: 16.671

Review 3.  Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.

Authors:  Jung Min Shim; Jinhee Kim; Tanel Tenson; Ji-Young Min; Denis E Kainov
Journal:  Viruses       Date:  2017-08-12       Impact factor: 5.048

4.  Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.

Authors:  Daria Bulanova; Aleksandr Ianevski; Andrii Bugai; Yevhen Akimov; Suvi Kuivanen; Henrik Paavilainen; Laura Kakkola; Jatin Nandania; Laura Turunen; Tiina Ohman; Hanna Ala-Hongisto; Hanna M Pesonen; Marika S Kuisma; Anni Honkimaa; Emma L Walton; Valentyn Oksenych; Martina B Lorey; Dmitry Guschin; Jungmin Shim; Jinhee Kim; Thoa T Than; So Young Chang; Veijo Hukkanen; Evgeny Kulesskiy; Varpu S Marjomaki; Ilkka Julkunen; Tuula A Nyman; Sampsa Matikainen; Jani S Saarela; Famara Sane; Didier Hober; Gülsah Gabriel; Jef K De Brabander; Miika Martikainen; Marc P Windisch; Ji-Young Min; Roberto Bruzzone; Tero Aittokallio; Markus Vähä-Koskela; Olli Vapalahti; Arto Pulk; Vidya Velagapudi; Denis E Kainov
Journal:  Viruses       Date:  2017-09-25       Impact factor: 5.048

5.  Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.

Authors:  Christoph-Martin Ufermann; Andreas Domröse; Timo Babel; Anne Tersteegen; Sevgi Can Cengiz; Silvia Kathrin Eller; Katrin Spekker-Bosker; Ursula Regina Sorg; Irmgard Förster; Walter Däubener
Journal:  Front Cell Infect Microbiol       Date:  2019-06-05       Impact factor: 5.293

Review 6.  Interferons: Reprogramming the Metabolic Network against Viral Infection.

Authors:  Kavita Raniga; Chen Liang
Journal:  Viruses       Date:  2018-01-13       Impact factor: 5.048

Review 7.  Redox control in the pathophysiology of influenza virus infection.

Authors:  Ker-Kong Chen; Moeko Minakuchi; Kenly Wuputra; Chia-Chen Ku; Jia-Bin Pan; Kung-Kai Kuo; Ying-Chu Lin; Shigeo Saito; Chang-Shen Lin; Kazunari K Yokoyama
Journal:  BMC Microbiol       Date:  2020-07-20       Impact factor: 4.465

8.  Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection.

Authors:  Thrimendra Kaushika Dissanayake; Sascha Schäuble; Mohammad Hassan Mirhakkak; Wai-Lan Wu; Anthony Chin-Ki Ng; Cyril C Y Yip; Albert García López; Thomas Wolf; Man-Lung Yeung; Kwok-Hung Chan; Kwok-Yung Yuen; Gianni Panagiotou; Kelvin Kai-Wang To
Journal:  Front Microbiol       Date:  2020-07-21       Impact factor: 5.640

Review 9.  A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents.

Authors:  Eva Zusinaite; Aleksandr Ianevski; Diana Niukkanen; Minna M Poranen; Magnar Bjørås; Jan Egil Afset; Tanel Tenson; Vidya Velagapudi; Andres Merits; Denis E Kainov
Journal:  Viruses       Date:  2018-08-12       Impact factor: 5.048

10.  Validation and Automation of a High-Throughput Multitargeted Method for Semiquantification of Endogenous Metabolites from Different Biological Matrices Using Tandem Mass Spectrometry.

Authors:  Jatin Nandania; Gopal Peddinti; Alberto Pessia; Meri Kokkonen; Vidya Velagapudi
Journal:  Metabolites       Date:  2018-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.